Bispecific antibodies are already being used in a considerable number of therapeutic applications, which are believed to further increase in the coming years. We will discuss them in this article.
In this article, we’ll explore the different types and formats of bsAbs, their unique features, and therapeutic applications. Additionally, we’ll highlight evitria’s role in advancing bsAb development.
With numerous bispecific formats available, each with its own unique features and advantages, making the right choice can be a complex yet crucial decision. In this article, we will explore the key considerations for choosing a bsAb format.
Developing bispecific antibodies (bsAbs) presents a series of challenges, ranging from optimizing binding affinity and ensuring correct assembly to managing immunogenicity and achieving efficient manufacturing.
This blog post endeavors to explore the compelling advantages presented by bsAbs and their profound impact on medicine. Additionally, we will highlight the expertise and support provided by evitria in driving forward research and development in this field.
Bispecific drugs hold immense promise in revolutionizing therapeutic interventions across various medical fields. In this article, we explore three examples of bispecifics and their applications, illuminating their remarkable potential in advancing patient care.
Both monoclonal and bispecific antibodies come with numerous benefits, but have several differences that set them apart. We will review them in this article.
Recorded Presentation: From mAb to bAb Developing drugs requires navigating complex technical, practical, and strategic challenges […]
Bispecific antibodies offer whole new possibilities in fields like targeted therapies or diagnostics. In this article, we will focus on how bsAbs are produced.
From the application in medicine and science to recombinant antibody production and the advantages of recombinant Abs in contrast to traditional monoclonal antibodies, this article will teach you all you need to know about recombinant antibodies.
Generally speaking, antibodies of any kind, including recombinant and afucosylated antibodies, are Y-shaped proteins produced by the human body. As they are able to identify and neutralize foreign objects – in other words viruses – they play a major contributing role in keeping our body and immune system healthy.
Antibody-dependent cellular cytotoxicity is a key process of the immune system’s arsenal to ward off cancerous cells and infections. We show you important definitions and the ADCC mechanism and key facts on ADCC antibodies in this post.